Phase 1a clinical

Related by string. * phases . Phases . phase . PHASE . PHASES : Phase III clinical trials . Phase III trials . Phase 2b clinical . pivotal Phase III . ongoing Phase 1b / 1As . 1as . 1AD . 1A : Item 1A Risk Factors . II Item 1A . caption Item 1A Risk . 1A 2A 3A / clinicals . CLINICAL . Clinicals . Clinical : placebo controlled clinical trials . Phase III clinical . Clinical Excellence NICE . clinical * *

Related by context. Frequent words. (Click for all words.) 80 Phase Ib clinical 77 Phase 1b clinical 77 Phase 2a clinical 77 phase IIa 76 Phase 2a trial 74 phase IIb 74 Phase Ia 73 Phase IIa clinical 73 phase 2a 72 Phase IIa trial 72 Phase 1a 71 Phase 1b trial 71 Phase 2b clinical 71 Phase IIb clinical 71 Phase Ib 70 placebo controlled clinical 70 Phase 2a 70 Phase 1b 70 Phase 2b study 69 multiple ascending dose 69 confirmatory Phase III 69 elotuzumab 69 Pivotal Phase III 69 Phase 2b trial 68 Phase IIa 68 registrational trial 68 Sym# 67 BCX# 67 Phase III clinical 67 Azedra 67 Phase IIb 67 registrational 67 randomized Phase III 67 Phase III Clinical Trial 66 Phase IIb trial 66 Phase 2b 66 deforolimus 66 IND submission 66 Phenoptin 66 pivotal Phase III 66 tanespimycin 66 axitinib 65 confirmatory Phase 3 65 ALN TTR# 65 Cloretazine R VNP#M 65 Hepatitis C HCV 65 single ascending dose 65 SCH # 65 relapsed refractory multiple myeloma 65 PRECiSE 65 multicenter clinical 65 teduglutide 65 MAP# 65 dose escalation trial 65 CoFactor 65 PRX # 65 PA# [002] 64 diabetic neuropathic pain 64 tezampanel 64 orally bioavailable 64 Amrubicin 64 pharmacokinetic studies 64 NGX# 64 unblinding 64 romidepsin 64 pharmacodynamic effects 64 Pivotal Phase 64 eltrombopag 64 GV# [001] 64 KNS # 64 Phase III 64 Pivotal Trial 64 celgosivir 64 MLN# 64 Phase IIa clinical trials 64 pertuzumab 64 BNC# 64 Carfilzomib 64 anticancer compound 64 OXi# 64 atacicept 63 CR# vcMMAE 63 OncoVEX GM CSF 63 TOCOSOL Paclitaxel 63 double blinded placebo 63 Synavive 63 ponatinib 63 Phase II 63 QNEXA 63 Clinical Trial Results 63 rNAPc2 63 HuMax CD# 63 IDX# 63 ICA # 63 PS# [001] 63 PREOS 63 NVA# 63 dose cohorts 63 Phase III Trial 63 TG# [001] 63 alvimopan

Back to home page